A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

por Jiang, Lili, Zang, Dan, Yi, Songgang, Li, Xiaofen, Yang, Changshan, Dong, Xiaoxian, Zhao, Chong, Lan, Xiaoying, Chen, Xin, Liu, Shouting, Liu, Ningning, Huang, Hongbiao, Shi, Xianping, Wang, Xuejun, Liu, Jinbao
Publicado 2016

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

por Liu, Ningning, Liu, Chunjiao, Li, Xiaofen, Liao, Siyan, Song, Wenbin, Yang, Changshan, Zhao, Chong, Huang, Hongbiao, Guan, Lixia, Zhang, Peiquan, Liu, Shouting, Hua, Xianliang, Chen, Xin, Zhou, Ping, Lan, Xiaoying, Yi, Songgang, Wang, Shunqing, Wang, Xuejun, Dou, Q. Ping, Liu, Jinbao
Publicado 2014

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

por Liu, Ningning, Li, Xiaofen, Huang, Hongbiao, Zhao, Chong, Liao, Siyan, Yang, Changshan, Liu, Shouting, Song, Wenbin, Lu, Xiaoyu, Lan, Xiaoying, Chen, Xin, Yi, Songgang, Xu, Li, Jiang, Lili, Zhao, Canguo, Dong, Xiaoxian, Zhou, Ping, Li, Shujue, Wang, Shunqing, Shi, Xianping, Dou, Ping Q., Wang, Xuejun, Liu, Jinbao
Publicado 2014